NCT03305458

Brief Summary

The investigators recently completed an NIMH R34 in which they piloted a patient- and provider-informed tablet-based toolkit designed to facilitate delivery of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) - a treatment that was selected because it addresses a wide range of symptoms using techniques shared by other treatments for emotional and behavioral disorders. The tablet-based toolkit consists of numerous components (e.g., videos, interactive games, drawing applications) that are designed to facilitate provider-patient interactions in a way that enhances children's engagement and supports adherence to the treatment model. The tablet-based toolkit was very well received by children, caregivers, and providers in the pilot evaluation. Moreover, all benchmarks for feasibility were met or exceeded. This study proposes to conduct a hybrid effectiveness-implementation trial to examine the extent to which the tablet intervention may improve fidelity, engagement, and children's mental health outcomes. The investigators will conduct a randomized controlled trial with 120 mental health providers and 360 families in partnership with dozens of clinics in the Carolinas and Florida. Providers will be assigned randomly to tablet-facilitated vs. standard TF-CBT. Youth aged 8-16 years with clinically elevated symptoms of PTSD will be recruited. Baseline and 3-, 6-, 9-, and 12-month post-baseline assessments will be conducted by independent, blind evaluators. Sessions will be videorecorded for observational coding of engagement and fidelity by independent raters blind to study hypotheses. The investigators will also examine costs and conduct semi-structured interviews with families, providers, supervisors, and agency leaders to inform future dissemination and implementation initiatives. Technology-based resources that are scalable, easy to use, and designed for efficient integration into everyday practice may have sustained national impact.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
713

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 10, 2017

Completed
12 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2023

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

June 6, 2025

Completed
Last Updated

June 6, 2025

Status Verified

May 1, 2025

Enrollment Period

4.4 years

First QC Date

October 4, 2017

Results QC Date

February 15, 2024

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Child Involvement Ratings Scale (CIRS)

    Child engagement will be measured via coding of audiotaped sessions by independent, trained raters who are blind to study purpose and hypotheses. The Child Involvement Ratings Scale (CIRS) will be used to code child engagement. Ten "child involvement" items-6 positive, 4 negative- are rated for each session on a 6-point scale. The minimum total score will be 0 and the maximum score is 50. For the outcome, a single average value will be presented. The positive-involvement items emphasize the extent to which children initiate discussions, demonstrate enthusiasm, self-disclose, and demonstrate understanding. Negative-involvement items address withdrawal or avoidance in treatment. Coders provide ratings based on two 10-min segments of session audiotapes (beginning at min 10 and min 40). Screening was conducted on enrolled participants.

    3 Month Timeline

  • Provider Treatment Fidelity (TPOCS)

    Fidelity to the TF-CBT protocol will be measured by independent, trained raters who are blind to the study purpose and hypotheses, coding audiotaped treatment sessions. The TF-CBT Version of the Therapy Process Observational Coding System for Child Psychotherapy (TF-CBT TPOCS-S), modified for the eTF-CBT condition, will be used to assess provider fidelity to each TF-CBT component. Two raters will review video-recorded treatment sessions, assessing the presence or absence of specific techniques and rating their extensiveness on a 6-point scale. The total score will range from a minimum of 0 to the maximum 78. The outcome will be presented as a single average value.

    3 Month Timeline

Secondary Outcomes (19)

  • Center for Epidemiological Studies Depression Scale for Children (CES-DC)

    Baseline, 3 Month, 6 Month, 9 Month, 12 Month

  • Therapeutic Alliance Scale for Children (TASC)

    3 Month

  • Child/Adolescent Satisfaction Questionnaire (CASQ).

    3 Month

  • The Shame Measure

    Baseline, 3 Month, 6 Month, 9 Month, 12 Month

  • The Child and Adolescent Trauma Screen (CATS) - Youth Version

    Baseline, 3 Month, 6 Month, 9 Month, 12 Month

  • +14 more secondary outcomes

Study Arms (2)

Treatment as usual

ACTIVE COMPARATOR

Trauma Focused Cognitive Behavioral Therapy

Behavioral: TFCBT

Tablet-Facilitated TF-CBT

EXPERIMENTAL

Standard treatment with the addition of in-treatment/session iPad activities

Behavioral: eTFCBT

Interventions

TFCBTBEHAVIORAL

treatment as usual

Treatment as usual
eTFCBTBEHAVIORAL

tablet-facilitated Trauma Focused Cognitive Behavioral Therapy (eTFCBT)

Tablet-Facilitated TF-CBT

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • victim of at least one potentially traumatic event (e.g. sexual/physical assault, witnessed violence, disaster, serious accident)
  • have at least one symptom on each PTSD symptom cluster (re-experiencing, avoidance, hyperarousal)

You may not qualify if:

  • exhibits psychotic symptoms (active hallucinations, delusions, impaired thought processes) by caregiver or child
  • significant cognitive disabilities, developmental delays, or pervasive developmental disorder
  • active suicidal or homicidal ideations
  • no consistent caregiver available to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Results Point of Contact

Title
Dr. Tatiana Davidson
Organization
Medical University of South Carolina

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2017

First Posted

October 10, 2017

Study Start

October 1, 2018

Primary Completion

February 27, 2023

Study Completion

October 26, 2023

Last Updated

June 6, 2025

Results First Posted

June 6, 2025

Record last verified: 2025-05

Locations